D-tert-Leucine | CAS:26782-71-8

We serve D-tert-Leucine CAS:26782-71-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
D-tert-Leucine

CAS No: 26782-71-8
Product Name: D-tert-Leucine
Other Name:
D-tert-Leucine
D-tert-Butylglycine
(2R)-2-amino-3,3-dimethylbutanoic acid
(R)-2-Amino-3,3-dimethylbutyric acid
D-tert-Leucine
(r)-tert-leucine
h-tbu-d-gly-oh
3-methyl-D-valine
3-Methylvaline
D-t-Butylglycine
 
Density: 1.0±0.1 g/cm3
Boiling Point: 217.7±23.0 °C at 760 mmHg
Melting Point: >300ºC
Molecular Formula: C6H13NO2
Molecular Weight: 131.173
Flash Point: 85.5±22.6 °C
Exact Mass: 131.094635
PSA: 63.32000
LogP: 0.55
Vapour Pressure: 0.1±0.9 mmHg at 25°C
Index of Refraction: 1.464
 
Specification
Appearance: White to off-white powder
Assay: ≥98.0%
Loss on drying: ≤0.5%
 
Application
Amino Acid Derivatives. Be used as pharmaceutical intermediates.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like D-tert-Leucine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,D-t-Butylglycine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(r)-tert-leucine Use and application,D-tert-Leucine technical grade,usp/ep/jp grade.


Related News: Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.4-Bromo-2-nitro-6-(trifluoromethyl)aniline manufacturer China’s basic chemical industry is developed, and the intermediate industry has also entered a mature stage. It is basically able to independently support the production needs of various domestic drug substances, which also brings cost advantages to Chinese drug substance companies. On the other hand, if there is insufficient supply of upstream products or price fluctuations, the sales of API products will also fluctuate in volume and price.Acetoacetanilide supplier Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.N,N-Diethyl-3-oxobutyramide vendor Active pharmaceutical ingredients directly impact disease.Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.